Innate Memory Reprogramming by Gold Nanoparticles Depends on the Microbial Agents That Induce Memory.
Candida albicans
Cells, Cultured
Cytokines
/ immunology
Gold
/ administration & dosage
Helicobacter pylori
Humans
Immunity, Innate
/ drug effects
Immunologic Memory
/ drug effects
Metal Nanoparticles
/ administration & dosage
Monocytes
/ drug effects
Staphylococcus aureus
beta-Glucans
/ pharmacology
innate immunity
innate memory
microbial agents
monocytes
nanoparticles
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2021
2021
Historique:
received:
01
08
2021
accepted:
14
10
2021
entrez:
22
11
2021
pubmed:
23
11
2021
medline:
15
1
2022
Statut:
epublish
Résumé
Innate immune memory, the ability of innate cells to react in a more protective way to secondary challenges, is induced by exposure to infectious and other exogeous and endogenous agents. Engineered nanoparticles are particulate exogenous agents that, as such, could trigger an inflammatory reaction in monocytes and macrophages and could therefore be also able to induce innate memory. Here, we have evaluated the capacity of engineered gold nanoparticles (AuNPs) to induce a memory response or to modulate the memory responses induced by microbial agents. Microbial agents used were in soluble
Identifiants
pubmed: 34804037
doi: 10.3389/fimmu.2021.751683
pmc: PMC8600232
doi:
Substances chimiques
Cytokines
0
beta-Glucans
0
Gold
7440-57-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
751683Informations de copyright
Copyright © 2021 Swartzwelter, Michelini, Frauenlob, Barbero, Verde, De Luca, Puntes, Duschl, Horejs-Hoeck, Italiani and Boraschi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5
pubmed: 29324233
Front Immunol. 2018 Dec 04;9:2869
pubmed: 30564249
J Immunol. 2006 Dec 1;177(11):8154-63
pubmed: 17114491
J Endotoxin Res. 2004;10(2):71-84
pubmed: 15119998
Cells. 2020 Jan 23;9(2):
pubmed: 31979412
Clin Microbiol Rev. 2006 Oct;19(4):597-613
pubmed: 17041136
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42
pubmed: 22988082
Cancer Res. 2019 Apr 1;79(7):1600-1611
pubmed: 30696658
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
J Hazard Mater. 2021 Jan 15;402:123793
pubmed: 33254802
Nature. 2007 Jun 21;447(7147):972-8
pubmed: 17538624
Semin Immunol. 2017 Dec;34:52-60
pubmed: 29066063
J Biol Chem. 2001 Nov 30;276(48):44856-64
pubmed: 11546774
Nanotoxicology. 2015 May;9(4):462-73
pubmed: 25119419
Front Immunol. 2019 Aug 06;10:1788
pubmed: 31447835
J Clin Invest. 2010 May;120(5):1645-62
pubmed: 20389019
Cell Host Microbe. 2012 Aug 16;12(2):223-32
pubmed: 22901542
Helicobacter. 2004 Jun;9(3):211-6
pubmed: 15165256
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7818-E7827
pubmed: 27856764
Infect Immun. 2012 Aug;80(8):2724-34
pubmed: 22615251
J Leukoc Biol. 2002 Apr;71(4):669-76
pubmed: 11927654
PLoS Pathog. 2017 Mar 2;13(3):e1006177
pubmed: 28253332
Front Microbiol. 2017 Dec 12;8:2447
pubmed: 29312166
ACS Appl Mater Interfaces. 2016 Oct 26;8(42):28437-28447
pubmed: 27670583
Science. 2014 Sep 26;345(6204):1251086
pubmed: 25258085
J Immunol. 2014 Oct 1;193(7):3600-12
pubmed: 25187652
J Immunol. 2000 Nov 15;165(10):5392-6
pubmed: 11067888
Infect Immun. 1992 Apr;60(4):1714-6
pubmed: 1548097
Gastroenterology. 1996 Aug;111(2):419-25
pubmed: 8690207
Infect Immun. 1981 Feb;31(2):716-22
pubmed: 7216470
Bioconjug Chem. 2017 Jan 18;28(1):88-97
pubmed: 27997136
J Immunol Res. 2020 Jun 15;2020:5812743
pubmed: 32626788
Nanomedicine (Lond). 2012 Dec;7(12):1917-30
pubmed: 23249335
Int J Mol Sci. 2020 Dec 18;21(24):
pubmed: 33353206
Nanotoxicology. 2017 Nov - Dec;11(9-10):1157-1175
pubmed: 29192556
Int J Mol Sci. 2020 May 29;21(11):
pubmed: 32486097
Sci Rep. 2017 Apr 21;7(1):1005
pubmed: 28432285
ACS Appl Mater Interfaces. 2018 Apr 18;10(15):12406-12416
pubmed: 29569901
Proc Soc Exp Biol Med. 1946 Mar;61:248-50
pubmed: 21024160
Nanoscale. 2020 May 28;12(20):11192-11200
pubmed: 32407430
Nat Rev Immunol. 2020 Jun;20(6):375-388
pubmed: 32132681
J Immunol. 2013 Oct 1;191(7):3896-904
pubmed: 23980205
Front Immunol. 2017 Jan 26;8:29
pubmed: 28184222
Crit Care. 2006;10(5):233
pubmed: 17044947
Cell Microbiol. 2003 Jan;5(1):25-40
pubmed: 12542468
J Med Microbiol. 2007 Feb;56(Pt 2):154-164
pubmed: 17244794
J Vasc Res. 2007;44(1):51-60
pubmed: 17167270
Cell. 2016 Jun 16;165(7):1658-1671
pubmed: 27212238
Part Fibre Toxicol. 2011 Feb 09;8(1):8
pubmed: 21306632
J Biol Chem. 2003 Mar 14;278(11):8869-72
pubmed: 12527755
Microbiology (Reading). 2004 Dec;150(Pt 12):3913-22
pubmed: 15583145
Nanomaterials (Basel). 2021 Jan 15;11(1):
pubmed: 33467414
Front Immunol. 2018 Feb 20;9:298
pubmed: 29515591
Trends Immunol. 2005 Apr;26(4):186-92
pubmed: 15797508
Methods Mol Biol. 2007;369:449-66
pubmed: 17656764
Mol Aspects Med. 2021 Feb;77:100897
pubmed: 32891423
Infect Immun. 2004 Nov;72(11):6446-54
pubmed: 15501775
Langmuir. 2011 Sep 6;27(17):11098-105
pubmed: 21728302
Cell Commun Signal. 2020 Oct 6;18(1):160
pubmed: 33023610
Nanomaterials (Basel). 2021 Apr 06;11(4):
pubmed: 33917456
J Exp Med. 2000 Jan 3;191(1):115-28
pubmed: 10620610
Front Immunol. 2017 Jun 26;8:734
pubmed: 28694812
Clin Vaccine Immunol. 2014 Apr;21(4):534-45
pubmed: 24521784
Front Immunol. 2018 Aug 22;9:1915
pubmed: 30186286
Semin Immunol. 2016 Aug;28(4):319-27
pubmed: 27264335
ACS Nano. 2010 Jul 27;4(7):3623-32
pubmed: 20553005
Front Immunol. 2020 Oct 06;11:566309
pubmed: 33123137
Semin Immunol. 2016 Aug;28(4):328-42
pubmed: 27402055
Front Immunol. 2018 Apr 19;9:799
pubmed: 29725331
J Biol Chem. 2014 Oct 3;289(40):27776-93
pubmed: 25100717
Front Immunol. 2021 Aug 06;12:692165
pubmed: 34421901